DENVER (Legal Newsline) – A class action lawsuit has been filed against Genzyme Corporation after a Colorado man claims it distributed and sold impure and untested drugs. Sometime prior to 2009, ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
(Refiles to insert dropped word "Cerezyme" in paragraph 15) * No quick answers to Genzyme's manufacturing woes * Competitors work to upgrade plants, reduce risk By Toni Clarke BOSTON, Oct 20 (Reuters) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Genzyme's woes following the shutdown of its Allston ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Genzyme Corp.’s partner Hospira Inc. (NYSE: HSP) has ...
BOSTON (Reuters) - The manufacturing debacle unfolding at Genzyme Corp is not just hurting its bottom line: it threatens to dent the company's reputation for years to come. Genzyme, which is one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback